Kangmei Pharma | 600518 - Ebitda

Stock Price
1.72
Daily Change
0 0%
Monthly
-2.82%
Yearly
-11.79%
Q2 Forecast
1.69

Kangmei Pharma reported CNY17.3M in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Avita Medical AUD -9.69M 12.21M Dec/2025
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Genomma Lab Internacional MXN 853.55M 10.4M Dec/2025
Hypermarcas BRL 729.21M 26.99M Dec/2025
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
IQVIA Holdings USD 1.05B 97M Dec/2025
Jiangsu Hengrui CNY 2.3B 678.46M Dec/2025
Kangmei Pharma CNY 17.3M 20.56M Jun/2025
Moderna USD -790M 582M Dec/2025
Organon & Co USD 383M 135M Dec/2025
Revvity USD 248.91M 48.52M Dec/2025
Sh Fosun Pharma CNY 1.69B 17.13M Jun/2025
Tectonic Therapeutic USD -21.18M 365K Dec/2025
Viatris USD 1B 151.5M Dec/2025
WuXi AppTec CNY 5.71B 1.36B Jun/2025
Xeris Pharmaceuticals USD 25.09M 7.67M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 531.61M 658.23M Jun/2025